[Pseudohypoaldosteronism type II].
Endoh
Akira
A
Department of Pediatrics, Hamamatsu Medical Center.
D002713:Chlorine / Q000378:metabolism; D003937:Diagnosis, Differential; D004039:Diet, Sodium-Restricted; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D015778:Minor Histocompatibility Antigens; D009154:Mutation; D024661:Potassium Channels, Inwardly Rectifying / Q000502:physiology; D011379:Prognosis; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D011546:Pseudohypoaldosteronism / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D012964:Sodium / Q000378:metabolism; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects; D049992:Sodium Chloride Symporters / Q000502:physiology; D000076204:WNK Lysine-Deficient Protein Kinase 1
D047908:Intracellular Signaling Peptides and Proteins; C086989:KCNJ1 protein, human; D015778:Minor Histocompatibility Antigens; D024661:Potassium Channels, Inwardly Rectifying; D049993:Sodium Chloride Symporter Inhibitors; D049992:Sodium Chloride Symporters; D002713:Chlorine; D012964:Sodium; D017346:Protein Serine-Threonine Kinases; D000076204:WNK Lysine-Deficient Protein Kinase 1; C498743:WNK1 protein, human; C433806:WNK4 protein, human